Who: Chimerix, Inc. and the US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)
What: BARDA awarded a contract to Chimerix for up to 1.7 million courses of the antiviral Tembexa (brincidofovir) as a...








